Zhenfeng Duan

University of Miami — United States

Medicine · Health Sciences

54h-index9.2kcitations163works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(36), Drug Transport and Resistance Mechanisms(24), RNA Interference and Gene Delivery(23), MicroRNA in disease regulation(22), RNA modifications and cancer(21)

Publications163 total

Role of extracellular matrix in chordoma progression and therapeutic resistance
Critical Reviews in Oncology/Hematology·2025
PDZK1 inhibits MRP2-mediated oxaliplatin chemosensitivity in hepatocellular carcinoma
Scientific Reports·2025Open Access
Chemogenetic ablation and regeneration of arterial valve in zebrafish
Biochemical and Biophysical Research Communications·2025· 1 cited
A mesh meta-analysis of the effects of non-drug interventions on sleep quality in patients with breast cancer
2025Open Access
Spatiotemporal expression of carnitine palmitoyltransferase I genes during zebrafish development and heart regeneration
The International Journal of Developmental Biology·2025Open Access
cpt1b Regulates Cardiomyocyte Proliferation Through Modulation of Glutamine Synthetase in Zebrafish
Journal of Cardiovascular Development and Disease·2024· 1 citedOpen Access
Advances of SS18-SSX fusion gene in synovial sarcoma: Emerging novel functions and therapeutic potentials
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2024· 9 cited
CDK12 is a promising therapeutic target for the transcription cycle and DNA damage response in metastatic osteosarcoma
Carcinogenesis·2024· 4 cited
Inhibition of discoidin domain receptor 1 (DDR1) as a new therapeutic strategy for osteosarcoma
Research Square (Research Square)·2024Open Access
Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
Scientific Reports·2024· 1 citedOpen Access
Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
Oncotarget·2024· 1 citedOpen Access
Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study
Clinical Orthopaedics and Related Research·2023· 2 citedOpen Access
Abstract 5010: Inhibition of discoidin domain receptor 1 (DDR1) as a new therapeutic strategy for osteosarcoma
Cancer Research·2023
Advances in the development of chordoma models for drug discovery and precision medicine
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2022· 8 cited
Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications
Journal of Nanobiotechnology·2022· 35 citedOpen Access
Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential
Cancer Letters·2022· 101 cited
Inhibition of CDK7-Dependent Transcriptional Addiction is a Potential Therapeutic Target in Synovial Sarcoma
SSRN Electronic Journal·2022Open Access
The Advances of the CRISPR/Cas9 Technology for Correcting Genetic Disorders: Using Sarcoma as a Model System
2021
Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation
Cancer Letters·2021· 34 citedOpen Access
Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
Cancer Control·2021· 4 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Francis J. Hornicek(25), Edwin Choy(14), Michael V. Seiden(14), Mansoor M. Amiji(14), Henry J. Mankin(10), David C. Harmon(7), Jacson Shen(7), Lara Milane(7), Feng Xu(5), Min Lin(5), Richard T. Penson(5), Diana E. Lamendola(5), Xianzhe Liu(4), Michiro Susa(4), Gregory M. Coté(4), Rushdia Z. Yusuf(4), Ming Liu(3), Huirong Shi(3), Tian Jian Lu(3), A. J. Feller(3)